ROBERT NELSEN Insider Trading $LYEL Lyell Immunopharma, Inc.
Get free email notifications about insider trading for ROBERT NELSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).
ROBERT NELSEN in Lyell Immunopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT NELSEN: Director
Holdings: 18,206,358 shares
Latest Transaction: Jun 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT NELSEN in Lyell Immunopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
| Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
Page: 1